VON RICKENBACH JOSEF H 4/A
4/A · Aileron Therapeutics, Inc. · Filed Apr 10, 2024
Insider Transaction Report
Form 4/AAmended
VON RICKENBACH JOSEF H
Director
Transactions
- Award
Stock Option (right to buy)
2024-02-28+2,725→ 2,725 totalExercise: $4.72Exp: 2034-02-27→ Common Stock (2,725 underlying)
Footnotes (1)
- [F1]This option was granted on February 28, 2024. The shares underlying the option are scheduled to vest in full on the earlier of (i) February 28, 2025 or (ii) the date of the Issuer's 2024 Annual Meeting of Stockholders.